Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-541468 next-day driving performance crossover study in older adults
NL-OMON48154Active, not recruiting
- Sponsor
- Idorsia
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of daridorexant in Insomnia (4 arms), sponsored by Idorsia. Primary endpoint: Standard deviation of lateral position. Started Mar 2019; status: active, not recruiting.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON48154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48154.